Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation.
- labwebsite20170701
- Sep 3, 2024
- 1 min read
The article Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation was published in ACS Pharmacology & Translational Science, 2024 August 1.
(doi: 10.1021/acsptsci.4c00127)
(SCI, IF=4.9, 30/354; Pharmacology & Pharmacy)
Comments